Association of ST elevation with apical aneurysm in hypertrophic cardiomyopathy

Ozcan Ozeke1, Cagatay Ertan2, Gokhan Keskin2

  • 1Turkiye Yuksek Ihtisas Training and Research Hospital, Department of Cardiology, Ankara, Turkey.

Indian Heart Journal
|October 4, 2015
PubMed

Insights

Electrocardiographic ST-segment elevation (STE) in leads V4-6 is a strong indicator of apical aneurysms in hypertrophic cardiomyopathy (HCM) patients. This finding aids in detecting this often-missed condition, improving diagnosis and patient care.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrocardiography

Background:

  • Apical aneurysms are an underrecognized complication of hypertrophic cardiomyopathy (HCM).
  • Echocardiography may miss apical aneurysms due to poor image quality of the left ventricular apex.
  • Electrocardiography (ECG) may offer an alternative diagnostic clue.

Purpose of the Study:

  • To compare electrocardiographic ST-segment elevation (STE) in HCM patients with and without apical aneurysms.
  • To assess the diagnostic utility of STE in identifying apical aneurysms in HCM.

Main Methods:

  • A clinical review utilizing MEDLINE literature search and laboratory data.
  • Analysis of electrocardiographic parameters, specifically STE in V4-6 leads.
  • Comparison of STE prevalence between HCM patients with and without apical aneurysms.

Main Results:

  • A significant association was found between STE in V4-6 leads and the presence of apical aneurysms in HCM patients (93% vs 7%, p<0.001).
  • A strong positive correlation (Spearman's ρ=0.895, p<0.001) was observed between STE in V4-6 and apical aneurysm presence.
  • The study included 29 HCM patients without apical aneurysm and 28 with apical aneurysm.

Conclusions:

  • STE in V4-6 leads is a valuable marker for detecting apical aneurysms in HCM.
  • Clinicians, especially echocardiographers, should consider ECG findings, particularly STE in V4-6, for diagnosing apical aneurysms in HCM.
  • Increased attention to ECG may improve the detection of overlooked apical aneurysms in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
745
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
892
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
815
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K